Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
DOC logo DOC
Upturn stock ratingUpturn stock rating
DOC logo

Healthpeak Properties Inc (DOC)

Upturn stock ratingUpturn stock rating
$18.54
Last Close (24-hour delay)
Profit since last BUY1.76%
upturn advisory
Consider higher Upturn Star rating
BUY since 5 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

07/10/2025: DOC (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Number of Analysts

rating

20 Analysts rated it

Well-followed company, solid analyst reports, reliable data for confident investing.

1 Year Target Price $22.62

1 Year Target Price $22.62

Analysts Price Target For last 52 week
$22.62 Target price
52w Low $16.54
Current$18.54
52w High $22.31

Analysis of Past Performance

Type Stock
Historic Profit 3.71%
Avg. Invested days 44
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 07/10/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 12.69B USD
Price to earnings Ratio 44.54
1Y Target Price 22.62
Price to earnings Ratio 44.54
1Y Target Price 22.62
Volume (30-day avg) 20
Beta 1.01
52 Weeks Range 16.54 - 22.31
Updated Date 07/10/2025
52 Weeks Range 16.54 - 22.31
Updated Date 07/10/2025
Dividends yield (FY) 6.97%
Basic EPS (TTM) 0.41

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 9.99%
Operating Margin (TTM) 18.85%

Management Effectiveness

Return on Assets (TTM) 1.74%
Return on Equity (TTM) 3.32%

Valuation

Trailing PE 44.54
Forward PE 76.34
Enterprise Value 21798425255
Price to Sales(TTM) 4.54
Enterprise Value 21798425255
Price to Sales(TTM) 4.54
Enterprise Value to Revenue 7.79
Enterprise Value to EBITDA 12.79
Shares Outstanding 694732032
Shares Floating 691946230
Shares Outstanding 694732032
Shares Floating 691946230
Percent Insiders 0.29
Percent Institutions 97.63

ai summary icon Upturn AI SWOT

Healthpeak Properties Inc

stock logo

Company Overview

overview logo History and Background

Healthpeak Properties, Inc. (formerly HCP, Inc.) was founded in 1985 as Health Care Property Investors, Inc. It is a REIT specializing in healthcare real estate. Initially focused on nursing homes, the company diversified over time into hospitals, medical office buildings, and life science facilities. Key milestones include strategic acquisitions and portfolio repositioning to focus on higher-growth segments.

business area logo Core Business Areas

  • Life Science: Owns, manages, and develops life science properties, catering to pharmaceutical, biotechnology, and medical device companies.
  • Medical Office: Owns and operates medical office buildings leased to physician groups, hospitals, and other healthcare providers.
  • Continuing Care Retirement Communities (CCRC): Owns properties leased and managed by operators of independent and assisted living facilities. Healthpeak exited this segment in 2023 with the sale of its CCRC portfolio.

leadership logo Leadership and Structure

The CEO of Healthpeak Properties is Scott Brinker. The company is structured as a Real Estate Investment Trust (REIT) with a Board of Directors overseeing management.

Top Products and Market Share

overview logo Key Offerings

  • Life Science Real Estate: Provides lab and office space for life science companies, crucial for research and development. Market share data isn't precisely defined but Healthpeak competes with Alexandria Real Estate Equities. Key competitors include Alexandria Real Estate Equities (ARE), BioMed Realty (privately held by Blackstone), and Ventas (VTR). Revenues from this segment are a substantial portion of total revenue.
  • Medical Office Buildings (MOBs): Offers outpatient medical office space for physicians and healthcare providers. Market share data is fragmented across many regional players. Competitors include Healthcare Trust of America (HTA) before its merger with Physicians Realty Trust (DOC), Physicians Realty Trust (DOC), and many private regional real estate companies. Revenue is also generated by managing/leasing the MOBs.

Market Dynamics

industry overview logo Industry Overview

The healthcare real estate industry is driven by aging demographics, increased healthcare spending, and advancements in medical technology. The sector is becoming increasingly specialized with demand growing for modern life science research and development facilities and convenient outpatient care.

Positioning

Healthpeak positions itself as a premier owner and developer of high-quality life science and medical office properties in key innovation clusters. Its competitive advantage lies in its strategic focus, strong relationships with leading healthcare providers, and proven development capabilities.

Total Addressable Market (TAM)

The TAM for healthcare real estate is in the hundreds of billions of dollars. Healthpeak is well-positioned to capitalize on a portion of this TAM through its specialized focus and strategic investments. The estimated TAM for life science real estate alone is a significant figure, which Healthpeak is addressing through its development and acquisition activities.

Upturn SWOT Analysis

Strengths

  • Strong portfolio of high-quality assets
  • Strategic focus on life science and medical office buildings
  • Experienced management team
  • Solid balance sheet
  • Established relationships with leading healthcare providers

Weaknesses

  • Concentration in specific geographic markets
  • Exposure to tenant credit risk
  • Sensitivity to interest rate fluctuations
  • Dependence on key tenants and operators

Opportunities

  • Growing demand for life science and medical office space
  • Strategic acquisitions and developments
  • Expansion into new geographic markets
  • Increased focus on sustainable building practices
  • Development of new products and services

Threats

  • Economic downturn
  • Increased competition
  • Changes in healthcare regulations
  • Rising interest rates
  • Tenant bankruptcies

Competitors and Market Share

competitor logo Key Competitors

  • ARE
  • VTR
  • DOC

Competitive Landscape

Healthpeak's advantages compared to its competitors include its strategic focus, high-quality portfolio, and strong relationships. Disadvantages may include its concentration in specific geographic markets and exposure to tenant credit risk.

Major Acquisitions

Cambridge Discovery Park Portfolio

  • Year: 2021
  • Acquisition Price (USD millions): 587
  • Strategic Rationale: Enhanced presence in the Cambridge, MA life science market, a leading innovation hub.

Growth Trajectory and Initiatives

Historical Growth: Healthpeak's historical growth has been driven by acquisitions, developments, and organic growth within its portfolio. Examining historical revenue and FFO growth provides insights into its past performance.

Future Projections: Future growth projections for Healthpeak are based on analyst estimates and the company's own guidance. These projections take into account factors such as demand for life science and medical office space, development activity, and acquisition opportunities.

Recent Initiatives: Recent strategic initiatives undertaken by Healthpeak include acquisitions and development projects focused on life science and medical office properties. The sale of its CCRC business also marks a strategic pivot.

Summary

Healthpeak Properties is a well-established REIT focusing on life science and medical office properties. The strategic shift away from CCRCu2019s strengthens its focus on higher growth sectors. While strong in core markets, Healthpeak faces risks from interest rates and tenant stability. Continued strategic acquisitions and developments will be crucial for future growth. The total addressable market is very attractive.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Healthpeak Properties Inc. Investor Relations
  • SEC Filings
  • MarketWatch
  • Yahoo Finance
  • Analyst Reports
  • Statista

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Market share data are estimates and may vary. Investment decisions should be based on thorough research and consultation with a financial advisor.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Healthpeak Properties Inc

Exchange NYSE
Headquaters Denver, CO, United States
IPO Launch date 1987-11-05
President, CEO & Director Mr. Scott M. Brinker
Sector Real Estate
Industry REIT - Healthcare Facilities
Full time employees 387
Full time employees 387

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery.